Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tonkin

Showing results (221-230 of 338) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|December 29, 2000
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID studyA M Tonkin, D Colquhoun, J Emberson, et al.
Internal Medicine Journal|July 4, 2012
Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborativeC M Astley, A M Tonkin, L J Mahar, et al.
Circulation|April 6, 2005
White blood cell count predicts reduction in coronary heart disease mortality with pravastatinRalph A H Stewart, Harvey D White, Adrienne C Kirby, et al.
The Medical Journal of Australia|October 17, 2002
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?Paul P Glasziou, Simon D Eckermann, Sarah E Mulray, et al.
Diabetes Research and Clinical Practice|January 26, 2010
Waist circumference has heterogeneous impact on development of diabetes in different populations: longitudinal comparative study between Australia and IranNassir Rostambeigi, Jonathan E Shaw, Robert C Atkins, et al.
Geroscience|August 23, 2023
Sex-dependent associations of plasma high-density lipoprotein cholesterol and mortality risk in healthy older men and women: two prospective cohort studiesSultana Monira Hussain, Andrew M Tonkin, Gerald F Watts, et al.
Science (New York, N.Y.)|October 23, 2004
Mycobacterial Ku and ligase proteins constitute a two-component NHEJ repair machineMarina Della, Phillip L Palmbos, Hui-Min Tseng, et al.
The Lancet. Healthy Longevity|March 7, 2022
Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trialRakibul M Islam, Robin J Bell, David J Handelsman, et al.
Clinical Pharmacology and Therapeutics|June 21, 2020
Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly PopulationJoshua P Lewis, Moeen Riaz, Sophia Xie, et al.
The Medical Journal of Australia|September 23, 2008
How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000Lei Chen, Sophie L Rogers, Stephen Colagiuri, et al.
Pageof 34

Showing results (221-230 of 338) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|December 29, 2000
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID studyA M Tonkin, D Colquhoun, J Emberson, et al.
Internal Medicine Journal|July 4, 2012
Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborativeC M Astley, A M Tonkin, L J Mahar, et al.
Circulation|April 6, 2005
White blood cell count predicts reduction in coronary heart disease mortality with pravastatinRalph A H Stewart, Harvey D White, Adrienne C Kirby, et al.
The Medical Journal of Australia|October 17, 2002
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?Paul P Glasziou, Simon D Eckermann, Sarah E Mulray, et al.
Diabetes Research and Clinical Practice|January 26, 2010
Waist circumference has heterogeneous impact on development of diabetes in different populations: longitudinal comparative study between Australia and IranNassir Rostambeigi, Jonathan E Shaw, Robert C Atkins, et al.
Geroscience|August 23, 2023
Sex-dependent associations of plasma high-density lipoprotein cholesterol and mortality risk in healthy older men and women: two prospective cohort studiesSultana Monira Hussain, Andrew M Tonkin, Gerald F Watts, et al.
Science (New York, N.Y.)|October 23, 2004
Mycobacterial Ku and ligase proteins constitute a two-component NHEJ repair machineMarina Della, Phillip L Palmbos, Hui-Min Tseng, et al.
The Lancet. Healthy Longevity|March 7, 2022
Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trialRakibul M Islam, Robin J Bell, David J Handelsman, et al.
Clinical Pharmacology and Therapeutics|June 21, 2020
Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly PopulationJoshua P Lewis, Moeen Riaz, Sophia Xie, et al.
The Medical Journal of Australia|September 23, 2008
How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000Lei Chen, Sophie L Rogers, Stephen Colagiuri, et al.
Pageof 34